Skip to content

Author

D. Sarikaya

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Adjuvant Docetaxel–Cyclophosphamide Versus Anthracycline–Taxane Chemotherapy in Stage I–III HR-Positive/HER2-Negative Breast Cancer: A Real-World Propensity Score Overlap-Weighted Cohort Study

Findings support individualized adjuvant chemotherapy selection and warrant confirmation in larger cohorts with longer follow-up, particularly regarding the incremental benefit of anthracyclines.

Perihan Perkin, D. Sarikaya, H. Karakaş et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.